143 related articles for article (PubMed ID: 8099488)
1. CD4+ lymphocyte level and rate of decline as predictors of AIDS in intravenous drug users with HIV infection.
Alcabes P; Schoenbaum EE; Klein RS
AIDS; 1993 Apr; 7(4):513-7. PubMed ID: 8099488
[TBL] [Abstract][Full Text] [Related]
2. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
[TBL] [Abstract][Full Text] [Related]
4. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
[TBL] [Abstract][Full Text] [Related]
5. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users.
Alcabes P; Muñoz A; Vlahov D; Friedland G
Ann Epidemiol; 1994 Jan; 4(1):17-26. PubMed ID: 7911376
[TBL] [Abstract][Full Text] [Related]
6. Correlates of the rate of decline of CD4+ lymphocytes among injection drug users infected with the human immunodeficiency virus.
Alcabes P; Schoenbaum EE; Klein RS
Am J Epidemiol; 1993 May; 137(9):989-1000. PubMed ID: 8100395
[TBL] [Abstract][Full Text] [Related]
7. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up.
Phillips AN; Sabin CA; Elford J; Bofill M; Lee CA; Janossy G
AIDS; 1993 Jul; 7(7):975-80. PubMed ID: 8102854
[TBL] [Abstract][Full Text] [Related]
8. Continued drug use and other cofactors for progression to AIDS among injecting drug users.
Ronald PJ; Robertson JR; Elton RA
AIDS; 1994 Mar; 8(3):339-43. PubMed ID: 7913328
[TBL] [Abstract][Full Text] [Related]
9. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
10. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.
Burack JH; Barrett DC; Stall RD; Chesney MA; Ekstrand ML; Coates TJ
JAMA; 1993 Dec; 270(21):2568-73. PubMed ID: 7901433
[TBL] [Abstract][Full Text] [Related]
11. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study.
Saah AJ; Muñoz A; Kuo V; Fox R; Kaslow RA; Phair JP; Rinaldo CR; Detels R; Polk BF
Am J Epidemiol; 1992 May; 135(10):1147-55. PubMed ID: 1352940
[TBL] [Abstract][Full Text] [Related]
12. Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users.
Galai N; Margolick JB; Astemborski J; Vlahov D
Clin Immunol Immunopathol; 1996 May; 79(2):134-41. PubMed ID: 8620619
[TBL] [Abstract][Full Text] [Related]
13. Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam.
Mientjes GH; van Ameijden EJ; van den Hoek AJ; Coutinho RA
AIDS; 1992 Feb; 6(2):207-12. PubMed ID: 1558718
[TBL] [Abstract][Full Text] [Related]
14. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users.
Fernández-Cruz E; Desco M; Garcia Montes M; Longo N; Gonzalez B; Zabay JM
AIDS; 1990 Oct; 4(10):987-94. PubMed ID: 1979743
[TBL] [Abstract][Full Text] [Related]
15. The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users.
Lyles CM; Margolick JB; Astemborski J; Graham NM; Anthony JC; Hoover DR; Vlahov D
AIDS; 1997 Aug; 11(10):1255-62. PubMed ID: 9256944
[TBL] [Abstract][Full Text] [Related]
16. Estimation of time since infection using longitudinal disease-marker data.
Dubin N; Berman S; Marmor M; Tindall B; Des Jarlais D; Kim M
Stat Med; 1994 Feb; 13(3):231-44. PubMed ID: 7911249
[TBL] [Abstract][Full Text] [Related]
17. Acquired immunodeficiency syndrome (AIDS) risk in recent and long-standing human immunodeficiency virus type 1 (HIV-1)-infected patients with similar CD4 lymphocyte counts.
Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
Am J Epidemiol; 1993 Nov; 138(10):870-8. PubMed ID: 7901990
[TBL] [Abstract][Full Text] [Related]
18. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
19. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
[TBL] [Abstract][Full Text] [Related]
20. Clinical and epidemiological implications of the Centers for Disease Control/World Health Organization reclassification of AIDS cases.
Brettle RP; Gore SM; Bird AG; McNeil AJ
AIDS; 1993 Apr; 7(4):531-9. PubMed ID: 8099489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
